BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 37874419)

  • 1. Integrated analysis of single-cell and bulk RNA-sequencing reveals the poor prognostic value of ABCA1 in gastric adenocarcinoma.
    Shen K; Ke S; Chen B; Gao W
    Discov Oncol; 2023 Oct; 14(1):189. PubMed ID: 37874419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KYNU as a Biomarker of Tumor-Associated Macrophages and Correlates with Immunosuppressive Microenvironment and Poor Prognosis in Gastric Cancer.
    Shen K; Chen B; Yang L; Gao W
    Int J Genomics; 2023; 2023():4662480. PubMed ID: 37954130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated analysis of single-cell and bulk RNA-sequencing data reveals the prognostic value and molecular function of THSD7A in gastric cancer.
    Shen K; Chen B; Yang L; Gao W
    Aging (Albany NY); 2023 Oct; 15(21):11940-11969. PubMed ID: 37905960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioinformatics Analysis Reveals Prognostic Significance of the Macrophage Marker Gene Signature in Gastric Adenocarcinoma.
    Li Z; Chen H; Chen Z; Xie L; Pan D
    Front Biosci (Landmark Ed); 2024 May; 29(5):172. PubMed ID: 38812299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of NQO1 overexpression for prognostic evaluation of gastric adenocarcinoma.
    Lin L; Qin Y; Jin T; Liu S; Zhang S; Shen X; Lin Z
    Exp Mol Pathol; 2014 Apr; 96(2):200-5. PubMed ID: 24384455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Martrilin-3 (MATN3) Overexpression in Gastric Adenocarcinoma and its Prognostic Significance.
    Wu PL; He YF; Yao HH; Hu B
    Med Sci Monit; 2018 Jan; 24():348-355. PubMed ID: 29343680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sineoculis homeobox homolog 1 protein as an independent biomarker for gastric adenocarcinoma.
    Lv H; Cui A; Sun F; Zhang Y; Li Y; Li L; Lin Z
    Exp Mol Pathol; 2014 Aug; 97(1):74-80. PubMed ID: 24866365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced Expression of Deubiquitinase USP33 Is Associated with Tumor Progression and Poor Prognosis of Gastric Adenocarcinoma.
    Chen Y; Pang X; Ji L; Sun Y; Ji Y
    Med Sci Monit; 2018 May; 24():3496-3505. PubMed ID: 29802710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immune-related genes and their determined immune cell microenvironment to predict the prognosis of gastric adenocarcinoma].
    Xia N; Xia L; Zhang WF; Zhou FX
    Zhonghua Yi Xue Za Zhi; 2022 Mar; 102(12):840-846. PubMed ID: 35330576
    [No Abstract]   [Full Text] [Related]  

  • 10. Integrated single-cell RNA sequencing analysis reveals a mesenchymal stem cell-associated signature for estimating prognosis and drug sensitivity in gastric cancer.
    Shen K; Chen B; Gao W
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):11829-11847. PubMed ID: 37410142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and validation of biomarkers for epithelial-mesenchymal transition-related cells to estimate the prognosis and immune microenvironment in primary gastric cancer by the integrated analysis of single-cell and bulk RNA sequencing data.
    Shen K; Ke S; Chen B; Zhang T; Wang H; Lv J; Gao W
    Math Biosci Eng; 2023 Jun; 20(8):13798-13823. PubMed ID: 37679111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The expression of metastasis-associated in colon cancer-1 and KAI1 in gastric adenocarcinoma and their clinical significance.
    Lu G; Zhou L; Zhang X; Zhu B; Wu S; Song W; Gong X; Wang D; Tao Y
    World J Surg Oncol; 2016 Oct; 14(1):276. PubMed ID: 27793161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive analysis of scRNA-Seq and bulk RNA-Seq reveals dynamic changes in the tumor immune microenvironment of bladder cancer and establishes a prognostic model.
    Tan Z; Chen X; Zuo J; Fu S; Wang H; Wang J
    J Transl Med; 2023 Mar; 21(1):223. PubMed ID: 36973787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CREM Is Correlated With Immune-Suppressive Microenvironment and Predicts Poor Prognosis in Gastric Adenocarcinoma.
    Yu K; Kuang L; Fu T; Zhang C; Zhou Y; Zhu C; Zhang Q; Zhang Z; Le A
    Front Cell Dev Biol; 2021; 9():697748. PubMed ID: 34938728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated expression of Nodal and YAP1 is associated with poor prognosis of gastric adenocarcinoma.
    Li P; Sun D; Li X; He Y; Li W; Zhao J; Wang Y; Wang H; Xin Y
    J Cancer Res Clin Oncol; 2016 Aug; 142(8):1765-73. PubMed ID: 27325246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of kallikrein 5 as a novel prognostic biomarker in gastric adenocarcinoma.
    Abuduhadeer X; Xu X; Aihesan K; Yilihamu M; Zhao Y; Zhang W
    J Clin Lab Anal; 2021 Oct; 35(10):e23958. PubMed ID: 34510543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation a prognostic model based on natural killer T cells marker genes for predicting prognosis and characterizing immune status in glioblastoma through integrated analysis of single-cell and bulk RNA sequencing.
    Hu J; Xu L; Fu W; Sun Y; Wang N; Zhang J; Yang C; Zhang X; Zhou Y; Wang R; Zhang H; Mou R; Du X; Li X; Hu S; Xie R
    Funct Integr Genomics; 2023 Aug; 23(3):286. PubMed ID: 37650991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological Significance, Related Molecular Changes and Tumor Immune Response Analysis of the Abnormal SWI/SNF Complex Subunit PBRM1 in Gastric Adenocarcinoma.
    Zhou Z; Huang D; Yang S; Liang J; Wang X; Rao Q
    Pathol Oncol Res; 2022; 28():1610479. PubMed ID: 35928964
    [No Abstract]   [Full Text] [Related]  

  • 19. Establishment of an endoplasmic reticulum stress-related signature predicting outcomes of gastric adenocarcinoma patients.
    Gong M; Wang J; Gao W; Liu Q; Chen J; Wang G; Zhang Q
    Front Genet; 2022; 13():944105. PubMed ID: 36147499
    [No Abstract]   [Full Text] [Related]  

  • 20. Integrated Bioinformatics Analysis for Identifying the Significant Genes as Poor Prognostic Markers in Gastric Adenocarcinoma.
    Li Y; Luo Y; Tian Q; Lai Y; Xu L; Yun H; Liang Y; Liao D; Gu R; Liu L; Yuan M; Li Y; Li Y; Lu M; Yong X; Zhang H
    J Oncol; 2022; 2022():9080460. PubMed ID: 35726219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.